Načítám výsledky…
Two years as an independent company – reaching over 900 million patients per year Two years ago, Sandoz became an independent company.
Twenty years ago, the approval of the world's first biosimilar - developed by Sandoz - changed the future of medicine.
Sandoz reported strong H1 2026 results, with biosimilars reaching a record one-third of total net sales and continued momentum across the...
Sandoz is a global leader in biosimilars and continues to pioneer worldwide patient access to high-quality, more affordable and potentially...
As a global leader in biosimilars, Sandoz is committed to pioneering access for patients by bringing high-quality, more affordable,...
Our purpose is pioneering access to medicines for patients globally. Sandoz offers a unique opportunity for talented and motivated pharmacy...
Skilled manager with experience in sourcing, procurement, operations, compliance and teams and project management in large international...
In his video, our CEO Richard Saynor shares how Sandoz plans to unlock its full potential through ambitious growth plans driven by a...
In an episode of the "Generations of Impact Series," Sandoz employee Grit Müller reflects on her 50-year career journey with the company. She...
Sandoz announced its full-year financial results for 2025, with strong year-on-year net sales growth of 5% at constant currencies and an...